Protagonist Therapeutics Inc buy Citigroup Inc.
Start price
19.03.26
/
50%
€88.00
Target price
19.03.27
€108.80
Performance (%)
-2.84%
Price
04.05.26
€85.50
Summary
This prediction is currently active. With a performance of -2.84%, the BUY prediction for Protagonist Therapeutics Inc by Citigroup_Inc_ is down slightly. This prediction currently runs until 19.03.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Protagonist Therapeutics Inc | -1.156% | -1.156% |
| iShares Core DAX® | 4,64 % | 7,49 % |
| iShares Nasdaq 100 | 4,47 % | 16,80 % |
| iShares Nikkei 225® | 7,67 % | 16,86 % |
| iShares S&P 500 | 2,47 % | 9,90 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics (PTGX) had its price target raised by Citigroup Inc. from $115.00 to $125.00. They now have a "buy" rating on the stock.
Ratings data for PTGX provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€74.00
10.11.25
10.11.25
€84.79
10.11.26
10.11.26
15.54%
04.05.26
04.05.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€43.60
07.08.25
07.08.25
-
07.08.26
07.08.26
96.10%
04.05.26
04.05.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€46.40
17.06.25
17.06.25
€62.32
17.06.26
17.06.26
84.27%
04.05.26
04.05.26